↓ Skip to main content

Antibody-Drug Conjugates

Overview of attention for book
Cover of 'Antibody-Drug Conjugates'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Antibody-Drug Conjugate (ADC) Clinical Pipeline: A Review.
  3. Altmetric Badge
    Chapter 2 Antibody–Drug Conjugate Target Selection: Critical Factors
  4. Altmetric Badge
    Chapter 3 Selecting an Optimal Antibody for Antibody–Drug Conjugate Therapy: Internalization and Intracellular Localization
  5. Altmetric Badge
    Chapter 4 Antibody–Drug Conjugate Payloads
  6. Altmetric Badge
    Chapter 5 Linker Technologies for Antibody–Drug Conjugates
  7. Altmetric Badge
    Chapter 6 In Vivo Testing of Drug-Linker Stability
  8. Altmetric Badge
    Chapter 7 Pharmacokinetics and ADME Characterizations of Antibody–Drug Conjugates
  9. Altmetric Badge
    Chapter 8 Safe Handling of Cytotoxic Compounds in a Biopharmaceutical Environment
  10. Altmetric Badge
    Chapter 9 Micro- and Mid-Scale Maleimide-Based Conjugation of Cytotoxic Drugs to Antibody Hinge Region Thiols for Tumor Targeting
  11. Altmetric Badge
    Chapter 10 Protocols for Lysine Conjugation
  12. Altmetric Badge
    Chapter 11 Engineering THIOMABs for Site-Specific Conjugation of Thiol-Reactive Linkers.
  13. Altmetric Badge
    Chapter 12 Enzymatic antibody modification by bacterial transglutaminase.
  14. Altmetric Badge
    Chapter 13 Formulation development of antibody-drug conjugates.
  15. Altmetric Badge
    Chapter 14 Conjugation Process Development and Scale-Up
  16. Altmetric Badge
    Chapter 15 Methods for Conjugating Antibodies to Nanocarriers
  17. Altmetric Badge
    Chapter 16 Drug-to-Antibody Ratio (DAR) by UV/Vis Spectroscopy
  18. Altmetric Badge
    Chapter 17 Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by Hydrophobic Interaction Chromatography and Reversed Phase High-Performance Liquid Chromatography
  19. Altmetric Badge
    Chapter 18 Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by LC-ESI-MS
  20. Altmetric Badge
    Chapter 19 Determination of Charge Heterogeneity and Level of Unconjugated Antibody by Imaged cIEF
  21. Altmetric Badge
    Chapter 20 Risk-Based Scientific Approach for Determination of Extractables/Leachables from Biomanufacturing of Antibody–Drug Conjugates (ADCs)
Attention for Chapter 11: Engineering THIOMABs for Site-Specific Conjugation of Thiol-Reactive Linkers.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
patent
1 patent

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Engineering THIOMABs for Site-Specific Conjugation of Thiol-Reactive Linkers.
Chapter number 11
Book title
Antibody-Drug Conjugates
Published in
Methods in molecular biology, August 2013
DOI 10.1007/978-1-62703-541-5_11
Pubmed ID
Book ISBNs
978-1-62703-540-8, 978-1-62703-541-5
Authors

Bhakta S, Raab H, Junutula JR, Sunil Bhakta, Helga Raab, Jagath R. Junutula, Bhakta, Sunil, Raab, Helga, Junutula, Jagath R.

Abstract

Antibody conjugates are used in many therapeutic and research applications and are generated by chemically linking a cysteine or lysine residue to potent chemotherapeutic drugs or other functional groups through a flexible linker. Recently, we have engineered THIOMABs (antibodies with engineered reactive cysteine residues) for site-specific conjugation and showed that these antibody conjugates display homogeneous labeling with optimal in vitro and in vivo characteristics. Here, we describe protocols for engineering, selection, and site-specific conjugation of THIOMABs with thiol-reactive linkers.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 26%
Student > Master 11 20%
Student > Ph. D. Student 11 20%
Student > Bachelor 3 6%
Student > Doctoral Student 2 4%
Other 5 9%
Unknown 8 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 14 26%
Chemistry 12 22%
Agricultural and Biological Sciences 8 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Veterinary Science and Veterinary Medicine 2 4%
Other 5 9%
Unknown 10 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2022.
All research outputs
#3,648,288
of 23,426,104 outputs
Outputs from Methods in molecular biology
#868
of 13,324 outputs
Outputs of similar age
#31,127
of 198,935 outputs
Outputs of similar age from Methods in molecular biology
#7
of 56 outputs
Altmetric has tracked 23,426,104 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,324 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,935 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.